Breaking News Instant updates and real-time market news.

GD

General Dynamics

$166.39

-3.42 (-2.01%)

19:27
05/19/19
05/19
19:27
05/19/19
19:27

General Dynamics upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs upgraded General Dynamics to Buy as prior headwinds are fully priced and now inflecting.

  • 29

    May

GD General Dynamics
$166.39

-3.42 (-2.01%)

02/15/19
02/15/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Coca-Cola (KO) downgraded to Neutral from Buy at Citi with analyst Wendy Nicholson saying the company's guidance implies 2019 earnings growth of plus or minus 1%. Coca-Cola has reported earnings per share of $2.00, plus or minus 10c, for the last eight years, with strong underlying growth offset by dilution from refranchising activities and currency headwinds. 2. General Dynamics (GD) downgraded to Neutral from Outperform at Credit Suisse with analyst Robert Springarn saying the acquisition of CSRA appears to be only "nominally accretive" to 2019, well short of his expectations, and says he believes the acquisition has significantly reduced the company's balance sheet flexibility and may limit future shareholder returns. 3. Ball Corp. (BLL) downgraded to Neutral from Buy at UBS with analyst Edlain Rodriguez saying while Ball's fundamentals "remain solid," a higher multiple "is a stretch" with the stock already up 45% over the past year. 4. Six Flags (SIX) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brett Andress saying he remains constructive on the broader theme park industry and the majority of Six Flags' growth pillars, but international upside had been a key component of his thesis and the significantly reduced visibility and potential downside prompts the downgrade. 5. LogMeln (LOGM) downgraded to Perform from Outperform at Oppenheimer and to Hold from Buy at Needham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link
04/25/19
JPMS
04/25/19
UPGRADE
Target $200
JPMS
Neutral
General Dynamics upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Seth Seifman upgraded General Dynamics to Neutral from Underweight and raised his price target for the shares to $200 from $188.
04/25/19
JPMS
04/25/19
UPGRADE
Target $200
JPMS
Neutral
JPMorgan upgrades General Dynamics to Neutral, sees fair valuation
JPMorgan analyst Seth Seifman upgraded General Dynamics to Neutral from Underweight and raised his price target for the shares to $200 from $188. General Dynamics has underperformed the market by~21% since the start of 2018, Seifman tells investors in a research note. The analyst now sees a "reasonable valuation" and and "fewer obstacles ahead" for the company. He thinks the long-term challenges to Aero profitability from lower G650 production and new competition are well understood at current share levels.
04/25/19
04/25/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Neutral at UBS with analyst Eric Sheridan saying while 2019 remains a year of transition, Facebook management has now produced multiple quarters of better than expected revenue and earnings. 2. American Express (AXP) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Betsy Graseck saying she believes its strong revenue growth remains intact given its record growth in proprietary cards, strong contribution from Millennials, fee-based products and its strong loan and transactional growth. 3. Novartis (NVS) upgraded to Buy from Neutral at Guggenheim with analyst Seamus Fernandez saying he is more confident that the company "can deliver several years of mid-single digit operating profit and EPS growth" through 2024. 4. Sirius XM (SIRI) upgraded to Buy from Hold at Pivotal Research with analyst Jeffrey Wlodarczak saying yesterday's post-earnings selloff was overdone as investors overreacted to slightly lower than expected new car installations and modestly lower than expected self-pay net subscriber additions. 5. General Dynamics (GD) upgraded to Neutral from Underweight at JPMorgan with analyst Seth Seifman saying General Dynamics has underperformed the market by~21% since the start of 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SYF

Synchrony

$33.95

-0.05 (-0.15%)

07:25
06/17/19
06/17
07:25
06/17/19
07:25
Hot Stocks
Synchrony reports May net charge-off rate 4.91% vs. 5.11% last month »

Reports May 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$77.76

1.385 (1.81%)

07:25
06/17/19
06/17
07:25
06/17/19
07:25
Conference/Events
Incyte to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

PSTI

Pluristem

$0.56

0.0001 (0.02%)

07:24
06/17/19
06/17
07:24
06/17/19
07:24
Hot Stocks
Pluristem presents its first proprietary serum-free cell therapy product »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

H

Hyatt

$74.68

-0.185 (-0.25%)

07:24
06/17/19
06/17
07:24
06/17/19
07:24
Hot Stocks
Hyatt announces plan for first Alila resort in Europe »

Hyatt announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREE

LendingTree

$386.02

-1.83 (-0.47%)

07:24
06/17/19
06/17
07:24
06/17/19
07:24
Conference/Events
LendingTree management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 27

    Jun

  • 13

    Nov

TTEC

TTEC Holdings

$44.26

0.65 (1.49%)

07:23
06/17/19
06/17
07:23
06/17/19
07:23
Recommendations
TTEC Holdings analyst commentary  »

TTEC Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EB

Eventbrite

$16.00

-0.41 (-2.50%)

07:22
06/17/19
06/17
07:22
06/17/19
07:22
Initiation
Eventbrite initiated  »

Eventbrite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTM

Verastem

$1.39

0.125 (9.88%)

07:22
06/17/19
06/17
07:22
06/17/19
07:22
Hot Stocks
Verastem presents Copiktra clinical data at EHA »

Verastem announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STL

Sterling Bancorp

$20.36

-0.01 (-0.05%)

07:21
06/17/19
06/17
07:21
06/17/19
07:21
Conference/Events
Sterling Bancorp management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

TC

TuanChe

$2.96

0.065 (2.25%)

07:21
06/17/19
06/17
07:21
06/17/19
07:21
Hot Stocks
TuanChe announces up to $20M share repurchase program »

TuanChe announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THO

Thor Industries

$54.30

-0.01 (-0.02%)

, UNFI

United Natural Foods

$10.28

-0.51 (-4.73%)

07:20
06/17/19
06/17
07:20
06/17/19
07:20
Recommendations
Thor Industries, United Natural Foods analyst commentary  »

Citi lowers price targets…

THO

Thor Industries

$54.30

-0.01 (-0.02%)

UNFI

United Natural Foods

$10.28

-0.51 (-4.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

AYX

Alteryx

$104.23

2.08 (2.04%)

07:19
06/17/19
06/17
07:19
06/17/19
07:19
Recommendations
Alteryx analyst commentary  »

Alteryx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRCL

Stericycle

$45.24

-0.41 (-0.90%)

07:19
06/17/19
06/17
07:19
06/17/19
07:19
Conference/Events
Stericycle management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 21

    Aug

BWEN

Broadwind Energy

$2.17

0.02 (0.93%)

07:18
06/17/19
06/17
07:18
06/17/19
07:18
Hot Stocks
Broadwind Energy announces $29M of new tower orders »

Broadwind Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$8.24

-0.37 (-4.30%)

07:17
06/17/19
06/17
07:17
06/17/19
07:17
Recommendations
Teva analyst commentary  »

Citi removes Teva from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REVG

REV Group

$12.99

-0.555 (-4.10%)

07:17
06/17/19
06/17
07:17
06/17/19
07:17
Recommendations
REV Group analyst commentary  »

REV Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIXX

Homology Medicines

$18.56

0.16 (0.87%)

07:16
06/17/19
06/17
07:16
06/17/19
07:16
Hot Stocks
Homology Medicines says single dose HMI-102 resulted in long-term PKU correction »

Homology Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNV

Synovus

$33.01

0.08 (0.24%)

07:15
06/17/19
06/17
07:15
06/17/19
07:15
Conference/Events
Synovus management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

, PFE

Pfizer

$42.75

0.24 (0.56%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Breaking Hot Stocks news story on Array BioPharma, Pfizer »

Array BioPharma up 59% to…

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

PFE

Pfizer

$42.75

0.24 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

ALNY

Alnylam

$70.04

-1.15 (-1.62%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Alnylam announces lumasiran results, full patient enrollment in ILLUMINATE-A, »

Alnylam announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$11.35

-0.31 (-2.66%)

07:13
06/17/19
06/17
07:13
06/17/19
07:13
Initiation
Amicus initiated  »

Amicus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 16

    Sep

PLX

Protalix

$0.42

-0.017 (-3.89%)

07:13
06/17/19
06/17
07:13
06/17/19
07:13
Hot Stocks
Protalix completes enrollment in Phase III Bright clinical trial of PRX-102 »

Protalix BioTherapeutics …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROP

Roper Technologies

$364.63

-0.43 (-0.12%)

07:12
06/17/19
06/17
07:12
06/17/19
07:12
Conference/Events
Roper Technologies management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

07:12
06/17/19
06/17
07:12
06/17/19
07:12
Initiation
Rattler Midstream initiated  »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RWLK

ReWalk Robotics

$5.21

-0.215 (-3.97%)

07:11
06/17/19
06/17
07:11
06/17/19
07:11
Upgrade
ReWalk Robotics rating change  »

ReWalk Robotics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.